StockNews.com initiated coverage on shares of Check-Cap (NASDAQ:CHEK – Get Free Report) in a research report issued on Sunday. The firm set a “sell” rating on the medical research company’s stock.
Check-Cap Stock Performance
Shares of CHEK stock opened at $1.63 on Friday. The company has a market capitalization of $9.54 million, a price-to-earnings ratio of -0.54 and a beta of 0.39. Check-Cap has a 52-week low of $1.61 and a 52-week high of $4.59. The company has a 50-day simple moving average of $1.90 and a two-hundred day simple moving average of $2.11.
About Check-Cap
Read More
- Five stocks we like better than Check-Cap
- What Are Dividend Champions? How to Invest in the Champions
- The Average 401k Balance by Age Explained
- What is the FTSE 100 index?
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- What is the Dow Jones Industrial Average (DJIA)?
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Receive News & Ratings for Check-Cap Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check-Cap and related companies with MarketBeat.com's FREE daily email newsletter.